Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen C Lazarus

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
Journal of Toxicology and Environmental Health. Part A|November 4, 2008
Associations between air pollution and peak expiratory flow among patients with persistent asthmaZhengmin Qian, Hung-Mo Lin, Vernon M Chinchilli, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 2014
Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapyMeiLan K Han, Nabihah Tayob, Susan Murray, et al.
Annals of the American Thoracic Society|April 1, 2022
Lung Function and the Risk of Exacerbation in the β-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease TrialTrisha M Parekh, Erika S Helgeson, John Connett, et al.
American Journal of Respiratory and Critical Care Medicine|June 13, 2015
Impact of Age and Sex on Response to Asthma TherapyRyan M Dunn, Erik Lehman, Vernon M Chinchilli, et al.
American Journal of Respiratory and Critical Care Medicine|June 1, 2022
Clinical Trial of Losartan for Pulmonary Emphysema: Pulmonary Trials Cooperative Losartan Effects on Emphysema Progression Clinical TrialRobert A Wise, Janet T Holbrook, Robert H Brown, et al.
The European Respiratory Journal|October 19, 2013
Tumour necrosis factor receptor-75 and risk of COPD exacerbation in the azithromycin trialPrescott G Woodruff, Wissam Chatila, John E Connett, et al.
Annals of the American Thoracic Society|September 15, 2018
Alignment of Inhaled Chronic Obstructive Pulmonary Disease Therapies with Published Strategies. Analysis of the Global Initiative for Chronic Obstructive Lung Disease Recommendations in SPIROMICSSohini Ghosh, Wayne H Anderson, Nirupama Putcha, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 14, 2023
Association of Sputum Eosinophilia With Easily Measured Type-2 Inflammatory Biomarkers in Untreated Mild Persistent AsthmaRonina Covar, Stephen C Lazarus, Jerry A Krishnan, et al.
Contemporary Clinical Trials|December 30, 2018
Adapting clinical trial design to maintain meaningful outcomes during a multicenter asthma trial in the precision medicine eraChristine A Sorkness, Tonya S King, Anne-Marie Dyer, et al.
Annals of the American Thoracic Society|November 18, 2021
Biomarkers to Predict Response to Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists in Adolescents and Adults with Mild Persistent AsthmaJerry A Krishnan, Stephen C Lazarus, Kathryn V Blake, et al.
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Journal of Toxicology and Environmental Health. Part A|November 4, 2008
Associations between air pollution and peak expiratory flow among patients with persistent asthmaZhengmin Qian, Hung-Mo Lin, Vernon M Chinchilli, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 2014
Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapyMeiLan K Han, Nabihah Tayob, Susan Murray, et al.
Annals of the American Thoracic Society|April 1, 2022
Lung Function and the Risk of Exacerbation in the β-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease TrialTrisha M Parekh, Erika S Helgeson, John Connett, et al.
American Journal of Respiratory and Critical Care Medicine|June 13, 2015
Impact of Age and Sex on Response to Asthma TherapyRyan M Dunn, Erik Lehman, Vernon M Chinchilli, et al.
American Journal of Respiratory and Critical Care Medicine|June 1, 2022
Clinical Trial of Losartan for Pulmonary Emphysema: Pulmonary Trials Cooperative Losartan Effects on Emphysema Progression Clinical TrialRobert A Wise, Janet T Holbrook, Robert H Brown, et al.
The European Respiratory Journal|October 19, 2013
Tumour necrosis factor receptor-75 and risk of COPD exacerbation in the azithromycin trialPrescott G Woodruff, Wissam Chatila, John E Connett, et al.
Annals of the American Thoracic Society|September 15, 2018
Alignment of Inhaled Chronic Obstructive Pulmonary Disease Therapies with Published Strategies. Analysis of the Global Initiative for Chronic Obstructive Lung Disease Recommendations in SPIROMICSSohini Ghosh, Wayne H Anderson, Nirupama Putcha, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 14, 2023
Association of Sputum Eosinophilia With Easily Measured Type-2 Inflammatory Biomarkers in Untreated Mild Persistent AsthmaRonina Covar, Stephen C Lazarus, Jerry A Krishnan, et al.
Contemporary Clinical Trials|December 30, 2018
Adapting clinical trial design to maintain meaningful outcomes during a multicenter asthma trial in the precision medicine eraChristine A Sorkness, Tonya S King, Anne-Marie Dyer, et al.
Annals of the American Thoracic Society|November 18, 2021
Biomarkers to Predict Response to Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists in Adolescents and Adults with Mild Persistent AsthmaJerry A Krishnan, Stephen C Lazarus, Kathryn V Blake, et al.
Pageof 9